Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Nova Minerals
NVA
US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 14.945
- +0.065+0.44%
Trading Apr 30 10:31 ET
814.85MMarket Cap-11.97P/E (TTM)
14.990High13.280Low64.51KVolume14.510Open14.880Pre Close938.58KTurnover0.23%Turnover RatioLossP/E (Static)54.52MShares28.09052wk High1.66P/B422.41MFloat Cap8.91052wk Low--Dividend TTM28.26MShs Float28.090Historical High--Div YieldTTM11.49%Amplitude8.910Historical Low14.549Avg Price1Lot Size
Bicara Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||
| Gross profit | |||||||
| Operating expense | 106.55%82.39M | 94.62%26.64M | 116.45%20.63M | 5.93%39.89M | 13.69M | 9.53M | 37.66M |
| Selling and administrative expenses | 102.44%18.77M | 116.13%6.75M | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| -General and administrative expense | 102.44%18.77M | 116.13%6.75M | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| Research and development costs | 107.79%63.62M | 88.25%19.88M | 128.62%15.86M | -2.22%30.62M | --10.56M | --6.94M | --31.31M |
| Operating profit | -106.55%-82.39M | -94.62%-26.64M | -116.45%-20.63M | -5.93%-39.89M | -13.69M | -9.53M | -37.66M |
| Net non-operating interest income expense | 1,009.67%14.58M | 350.88%5.87M | 24,107.69%3.15M | 1,316.67%1.31M | 1.3M | 13K | -108K |
| Non-operating interest income | 1,009.67%14.58M | 350.88%5.87M | 24,107.69%3.15M | 32,750.00%1.31M | --1.3M | --13K | --4K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | --112K |
| Other net income (expense) | -16,656.25%-13.41M | -49K | -13.33M | -80K | |||
| Other non- operating income (expenses) | ---- | ---- | ---- | -16,656.25%-13.41M | ---49K | ---13.33M | ---80K |
| Income before tax | -30.45%-67.81M | -67.04%-20.77M | 23.48%-17.48M | -37.35%-51.98M | -12.44M | -22.85M | -37.84M |
| Income tax | 3,640.00%187K | 3,620.00%186K | 0 | 400.00%5K | 5K | 0 | 1K |
| Net income | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Net income continuous Operations | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | ---12.44M | ---22.85M | ---37.85M |
| Minority interest income | |||||||
| Net income attributable to the parent company | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Preferred stock dividends | |||||||
| Other preferred stock dividends | |||||||
| Net income attributable to common stockholders | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Basic earnings per share | -164.77%-4.05 | -6.54%-0.39 | -138.02%-1.6 | 37.59%-1.5296 | -0.366 | -0.6722 | -2.451 |
| Diluted earnings per share | -164.77%-4.05 | -6.54%-0.39 | -138.02%-1.6 | 37.59%-1.5296 | -0.366 | -0.6722 | -2.451 |
| Dividend per share | |||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now